ABOUT

Arthur is a seasoned product executive with over two decades of experience in leading tech firms like IBM, Qlik, ETQ, and Tamr. He has a strong track record in launching successful SaaS products and driving revenue growth. Arthur has a passion for design thinking, customer-centric product development, and the transformative potential of AI across all industries. As a published thought leader and a compelling speaker, Arthur brings a blend of strategic leadership, data analytics expertise, and forward-thinking insights to the table.

Tanima is a rare leader with cross-functional subject matter expertise in both medical devices and combination drug-device systems for NAM, EMEA, LATAM and APAC. She brings her executive RA/QA leadership, agile R&D and operational “know-how” in total product life cycle management of complex hardware, software, platforms, and systems; used for measurement, detection, diagnosis, triage and treatment of various diseases and cancer. She has accelerated global market authorizations for combination products for mapping heart function and brain aging, cardiovascular diagnostics as well as tissue abnormality detection. As a multi-disciplined strategic advisor, Tanima has helped re-engineer, navigate, and simplify new product introduction business processes, develop and commercialize innovations including combination drug-device theranostic systems for nuclear medicine; computer-assisted surgical robots; cardiac PET imaging; MRI-based body composition analysis; radioisotope infusion sets; SaMD/SiMD plus novel AI/ML-enabled devices; telemedicine/telehealth remote patient monitoring platforms and pediatric expert systems using AI models. Ms.Ghosh is a graduate from McGill University (Physics) with two National Science and Engineering Research Council of Canada (NSERC) Industrial Research Fellowship Awards. She is a McGill certified Agile Scrum master, certified ISO-13485 lead auditor and she has completed the Executive Development Program from Queen’s School of Business. With numerous technical contributions to advance emerging hardware & software through patents & global regulatory submissions, Tanima has helped companies grow organically and through acquisitions as part of their SLT, IPO and M&A integration teams.

Stephanie Shaw is a seasoned regulatory affairs professional with over 26 years of experience in the medical device and pharmaceutical industries. With a background that spans organizations of all sizes, she has held executive leadership roles and brings diverse expertise in R&D, regulatory compliance (GMP, QMSR, MDSAP, MDR, and warning letter clearance), and regulatory affairs for Class I, II, III medical devices, and pharmaceuticals. Stephanie is adept at crafting and executing innovative global regulatory strategies, achieving success in streamline entry to global markets. As a trusted advisor, she guides organizations through complex regulatory challenges while shaping strategic decisions in a rapidly evolving global landscape. Stephanie holds a Ph.D. in Organic Chemistry from UC Riverside.

Arti Tandon, Ph.D. is a digital health leader, with deep expertise in digital health and Artificial Intelligence (AI)/ Machine Learning (ML) product strategy & development, and regulatory frameworks to drive innovation in healthcare. She specializes in product strategy & development, regulatory strategy, and cross-functional leadership, with a strong track record in digital health, SaMD, AI/ML, and precision medicine. Arti excels at aligning product vision with clinical and business needs, driving market fit, and ensuring compliance with regulatory standards to deliver innovative, patient-centered solutions. Her 20+ years of experience spans being part of entrepreneurial teams in top-tier academic institutions, global healthcare corporations, venture-backed startups, and the US FDA. Most recently, as a Digital Health Specialist at the FDA’s Digital Health Center of Excellence, she advanced regulatory approaches for digital health and AI/ML-enabled medical devices. In this role, she led technical assessments and fostered stakeholder engagement to ensure accessibility, safety and efficacy of cutting-edge digital health products. Previously, Dr. Tandon developed precision medicine solutions by integrating clinical and omics data, with ML algorithms at Phillips Research, N.A. and Astarte Medical, a pediatric precision nutrition start-up. Earlier in her career at Harvard Medical School, she honed her expertise in genomics, research methodologies, and data science, contributing to 35+ scientific publications. Arti received a BSc and MSc in Physics from Indian Institute of Technology, Kharagpur, India and a PhD in Physics from Boston University.

John has a broad-based background spanning operating/executive management, advisory and private equity roles, helping numerous companies develop and execute successful growth strategies. He has developed perspective from “all sides of the table,” having been a Partner with a Strategy/Mergers and Acquisition advisory firm, senior operating executive, and member of the investment committee of a venture capital firm. John is currently a Partner with J. Locke & Co, a merchant banking group focused on equity investments and turnarounds of Special Situations i.e., distressed or underperforming companies. John graduated with honors from Harvard University with an AB in Economics, and holds an MBA from the Kellogg School at Northwestern University.

Darwin understands that people are the greatest asset at any company and the key qualities that growth companies need to grow market share while enhancing their positive culture and team environment. He has a clinical background as a respiratory therapist of over 30 years including 12+ years of sales, business development, marketing and negotiations experience within medical device, diagnostics, distribution, ventilation, and sleep therapy, 8 years of sales leadership, 3 years of operations and extensive experience in negotiations and contract management before entering the entrepreneurial world of talent management.

Bob has been leading companies to success as CEO and/or President for over 30 years. He is a highly accomplished entrepreneur who started and favorably exited companies that he started, including MicroFridge, InvoiceCloud, and EngageSmart. As a sales-oriented generalist Bob believes in hiring top talent that collaborates to create simple business systems that drive long term success. In 2009, he formed a small founding team that commercialized his idea for an Electronic Bill Presentment and Payment (EBPP) solution. He and his team acquired several software solutions along the way and created EngageSmart which went public in 2021. In January of 2024 EngageSmart was taken private with a majority purchase by Vista Equity Partners in a $4B transaction. Through his experience, he has come to believe that it is the responsibility of senior managers and leaders to create systems of perpetual, profitable organic growth. With a notable track record of success, Bob considers himself to be one of the luckiest people on the planet. Currently as a strategic advisor with The Boston Foundation and Entrepreneurship for All, he is now focused on helping other entrepreneurs achieve similar success. Additionally, he serves on the board of directors for select companies and mentors CEOs. Bob obtained a BA in Applied Math with concentration in Computer Science from the University of Maine, a MS in Engineering Management from Northeastern University, and completed Harvard Business School’s Owner President Management program.